Medicines, medical devices and life sciences
We help medical device manufacturers, pharmaceutical companies, NHS bodies, investors and innovators to get their products to patients.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
We help medical device manufacturers, pharmaceutical companies, NHS bodies, investors and innovators to get their products to patients.
Then we will work with you to create a practical path for legal issues that drives medical products forward, from concept, development, approval and accreditation to adoption and deployment at scale. We understand that innovation – be that digital health or medical devices, to novel therapeutics and pioneering diagnostics – may need news ways of working to break down barriers to market access.
Our experience working with leading NHS Trusts, central Government and industry means we know the levers, constraints and ways of working that are likely to lead to success. Whether you are bringing new products to market, revolutionising pathways or expanding your business, we can help you navigate legal issues across the healthcare and life sciences sector, including regulatory compliance, AI, health data, IP, commercial, corporate and procurement.
Advising on requirements from pre-market authorisation to post-market surveillance for medical devices, health tech and digital solutions, including interactions with MHRA, General Pharmaceutical Council, CQC and other regulators.
Ensuring compliance with healthcare, medical regulatory, advertising, digital and consumer law, as well as national guidelines.
Lawyers with specialist AI-law training applying emerging regulation on software and AI to your business.
Including data protection law, healthcare specific guidance, Caldicott requirements and their application to data collection, storage and novel uses for developing medical technology.
Advising on strategic approach, drafting and negotiation of key contracts covering supply chain, distribution and commercialisation of products and services.
Advising on models for industry, NHS, funders, third sector and other stakeholders to work together to bring innovation to market.
Helping industry and the NHS use the new procurement law regime to drive adoption of new technology and products, including solutions to perceived barriers to participation and deployment at scale.
Protecting IPR rights at each stage of a product lifecycle, including when working with multiple funding streams and innovative partnership/collaboration models.
Advising on competition law issues.
Advising on early stage, venture capital, growth capital, development capital and venture debt transactions.